• Users Online: 142
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 14  |  Issue : 1  |  Page : 19-23

Evaluating the effect of midodrine on renal resistance index in patients with liver cirrhosis and ascites


1 Department of Tropical Medicine, Faculty of Medicine, Al-Azhar Assiut University, Assiut, Egypt
2 Department of Radiology, Faculty of Medicine, Al-Azhar Assiut University, Assiut, Egypt

Correspondence Address:
Hamdy M Moustafa
Gastroenterology and Hepatology, Tropical Medicine Department, Faculty of Medicine, Al-Azhar University, Assiut, Postal Code: 71111
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1687-1693.180465

Rights and Permissions

Background Portal hypertension, which occurs as a consequence of liver cirrhosis, leads to splenic vasodilatation and alterations in the systemic circulation. Arterial vasodilatation in the splanchnic circulation appears to play a central role in hemodynamic changes and in the decline in renal function in cirrhosis. Peripheral vasodilatation, which occurs as a part of alterations in the systemic circulation, may decrease the renal blood flow and subsequently raise plasma renin activity. Midodrine is a α agonist and acts as a peripheral vasoconstrictor; therefore, it may reduce plasma renin activity and improve renal function. Aim of the work The aim of the study was to evaluate the relationship between renal resistive indices (RIs) in cirrhotic patients before and after oral administration of 7.5 mg midodrine three times daily for 3 days. Patients and methods The study was conducted on 40 patients with liver cirrhosis and ascites and on 40 healthy controls from October 2014 to March 2015 at Al-Azhar University Hospital, Assiut, where all patients were subjected to history and clinical examination as well as to routine investigations such as total bilirubin, albumin, international normalized ratio, and serum creatinine. Patients underwent an abdominal ultrasound with duplex Doppler examination of the kidneys, and RI was calculated before and 3 days after oral intake of midodrine. Results Patients with liver cirrhosis and ascites had significantly higher RI in the right kidney (0.69 ± 0.101 vs. 0.57 ± 0.055,P < 0.001) and in the left kidney (0.69 ± 0.097 vs. 0.59 ± 0.047,P < 0.001) compared with healthy controls. After oral administration of midodrine for 3 days, RI showed significant improvement (RI = 0.928,P < 0.001) in the right kidney and in the left kidney (R = 0.993,P < 0.001). RI had significant positive correlation with Child–Pugh score (R = 0.75,P < 0.001, in the right kidney and R = 0.75,P < 0.001, in the left kidney) and significant positive correlation with Model for End-Stage Liver Disease score (R = 0.536,P < 0.008, in the right kidney and R = 0.487,P < 0.005, in the left kidney). Conclusion Oral midodrine improved renal hemodynamics as assessed by RI in cirrhotic patients. RI is correlated with severity of liver disease as assessed by Child–Pugh and Model for End-Stage Liver Disease scores.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed210    
    Printed1    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal